SequelSEC

Encompass Health Corp EHC

Services-Hospitals · CIK 0000785161 · Fiscal year ends 1231

Revenue
$5.94B
Fiscal year ended 2025-12-31
Operating income
Unavailable
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Encompass Health Corp (EHC) reported revenue of $5.94B and net income of $566.20M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Encompass Health Corp’s SEC filings, each linked to the filing it came from.

Income

Encompass Health Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$5.94B$5.37B$4.80B$4.35B$4.01B$3.57B$4.60B$4.28B$3.91B$3.64B
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailableUnavailableUnavailable$539.50M$559.60M$563.90M$612.10M$555.20M$578.30M$588.10M
Net income$566.20M$455.70M$352.00M$271.00M$412.20M$284.20M$358.70M$292.30M$271.10M$247.60M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 102.20Mshares 102.20Mshares 101.30Mshares 100.40Mshares 100.20Mshares 99.80Mshares 99.40Mshares 99.80Mshares 99.30Mshares 99.50M
Pretax income$953.00M$749.60M$607.20M$450.80M$505.00M$352.90M$562.30M$493.20M$496.40M$482.00M
Income tax expense$192.90M$150.20M$132.20M$100.10M$101.90M$74.70M$115.90M$118.90M$145.80M$163.90M
Diluted EPS$5.54$4.46$3.47$2.70$4.11$2.85$3.61$2.93$2.84$2.59
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$236.20M$209.20M$201.70M$154.30M$169.50M$151.60M$247.00M$220.20M$171.70M$133.40M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Encompass Health Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$72.20M$85.40M$69.10M$21.80M$49.40M$185.60M$60.00M$69.20M$54.40M$40.50M
Total assets$7.09B$6.53B$6.10B$5.64B$6.86B$6.45B$6.08B$5.18B$4.86B$4.68B
Current assets$905.90M$886.90M$841.80M$717.20M$921.40M$948.60M$755.80M$662.10M$702.20M$654.50M
Total liabilities$3.81B$3.69B$3.81B$3.77B$4.47B$4.44B$4.15B$3.36B$3.25B$3.61B
Current liabilities$836.40M$841.00M$656.40M$575.90M$748.80M$717.30M$721.00M$672.50M$517.50M$475.60M
Total equity incl. NCI$3.22B$2.79B$2.26B$1.83B$2.36B$1.97B$1.69B$1.56B$1.40B$910.60M
Temporary (mezzanine) equity$58.30M$56.50M$42.00M$35.60M$42.20M$31.60M$239.60M$261.70M$220.90M$138.30M
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$619.20M$593.00M$599.80M$524.80M$502.10M$563.00M$498.70M$459.90M$459.50M$432.00M
Goodwill$1.32B$1.28B$1.28B$1.26B$1.24B$1.23B$1.22B$2.10B$1.97B$1.93B
Long-term debt$2.45B$2.36B$2.69B$2.74B$3.24B$3.25B$3.02B$2.48B$2.55B$2.98B
Accounts payable$178.20M$171.00M$170.00M$132.90M$134.00M$115.00M$94.60M$90.00M$78.40M$68.30M

Cash flow

Encompass Health Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flowUnavailableUnavailableUnavailable$705.80M$715.80M$704.70M$635.30M$762.40M$658.30M$640.20M
Capital expendituresUnavailableUnavailableUnavailable$564.80M$524.60M$392.80M$372.40M$254.50M$225.80M$177.70M
Investing cash flow-$764.60M-$653.30M-$602.80M-$627.00M-$666.30M-$407.50M-$657.40M-$424.50M-$283.00M-$229.90M
Financing cash flow-$431.20M-$330.60M-$197.20M-$145.70M-$240.10M-$145.90M$48.20M-$321.20M-$359.90M-$416.40M
Net change in cash-$20.20M$18.90M$50.80M-$66.90M-$190.60M$151.30M$26.10M$16.70M$15.40M-$6.10M
Stock-based compensation$56.50M$48.30M$50.60M$29.20M$29.10M$25.60M$114.40M$85.90M$47.70M$27.40M
Common dividends paid$71.10M$62.80M$60.40M$99.00M$112.20M$111.80M$108.70M$100.80M$91.50M$83.80M
Common share repurchases$158.00M$31.10M$0$0$0$6.10M$45.90M$0$38.10M$65.60M
Depreciation & amortization$327.90M$299.60M$273.90M$243.60M$219.60M$203.00M$218.70M$199.70M$183.80M$172.60M

Derived

Encompass Health Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flowUnavailableUnavailableUnavailable$141.00M$191.20M$311.90M$262.90M$507.90M$432.50M$462.50M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailable8.7%5.7%11.9%11.1%12.7%
SBC / revenue1.0%0.9%1.1%0.7%0.7%0.7%2.5%2.0%1.2%0.8%
Current ratio1.08x1.05x1.28x1.25x1.23x1.32x1.05x0.98x1.36x1.38x
Revenue YoY growth10.5%11.9%10.4%8.3%12.6%-22.6%7.7%9.3%7.4%Unavailable
Net margin9.5%8.5%7.3%6.2%10.3%8.0%7.8%6.8%6.9%6.8%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailable11.0%8.1%6.0%5.8%4.9%
Long-term debt / equity0.76xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate20.2%20.0%21.8%22.2%20.2%21.2%20.6%24.1%29.4%34.0%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-01View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2016-12-31

Difference 18100000 exceeds tolerance 4681900.000. Presentation or filing-vintage differences need review.